Vali is a venture-backed biotechnology startup founded in 2013 to develop smart, programmable drug delivery systems. Our patent-pending multidrug-delivery platform technology can transport multiple drugs to tumors simultaneously, unlocking previously impossible cancer combination therapies. We can deliver therapeutic nucleotides (siRNA, mRNA, DNA) in addition to traditional small molecule drugs. Our next generation technology will activate payloads only when they are delivered to the correct cell type, giving an unprecedented level of specificity, efficacy and safety.
View Top Employees from Vali Nanomedical| Website | http://www.valinano.com |
| Revenue | $5.2 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2013 |
| Industry | Biotechnology, Drug Delivery, Pharmaceuticals, Science and Engineering, Healthcare, Nanotechnology, Therapeutics, Health Care |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Vali Nanomedical employee's phone or email?
Vali Nanomedical Questions
The Vali Nanomedical annual revenue was $5.2 million in 2024.
Vali Nanomedical is based in San Francisco, California.
The NAICS codes for Vali Nanomedical are [3254, 325, 32].
The SIC codes for Vali Nanomedical are [28, 283].
Related Companies
